Clicky

Alterity Therapeutics Limited(ATH) News

Date Title
Oct 2 Alterity Therapeutics Raises Profile with Multiple Data Presentations at the International Congress of Parkinson’s Disease and Movement Disorders®
Sep 30 Alterity Therapeutics Appoints Abby Macnish Niven as Chief Financial Officer
Jul 24 Alterity Therapeutics to Present at MST Financial Webinar
May 8 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
Feb 6 Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
Dec 21 Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
Dec 5 Alterity (ATHE) Up on Preclinical Parkinson's Treatment Data
Dec 4 Alterity Therapeutics to Host Webcast to Discuss ATH434 Efficacy Data in Primates and Recent Clinical Progress
Dec 4 Biotech Alterity Jumps On Upbeat Parkinson's Treatment Clinical Trial Data
Dec 4 Alterity Therapeutics Reports Positive Efficacy Data for ATH434 in a Primate Model of Parkinson’s Disease
Nov 27 Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy